Cargando…
Trends in antihypertensive drug utilization in British Columbia, 2004–2019: a descriptive study
BACKGROUND: Clinical guidelines for hypertension were updated with lower blood pressure targets following new studies in 2015; the real-world impact of these changes on antihypertensive drug use is unknown. We aimed to describe trends in antihypertensive drug utilization from 2004 to 2019 in British...
Autores principales: | Kim, Jason D., Fisher, Anat, Dormuth, Colin R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
CMA Impact Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10400081/ https://www.ncbi.nlm.nih.gov/pubmed/37527901 http://dx.doi.org/10.9778/cmajo.20220023 |
Ejemplares similares
-
Mandatory nonmedical switching from originator to biosimilar infliximab in patients with inflammatory arthritis and psoriasis in British Columbia: a cohort study
por: Fisher, Anat, et al.
Publicado: (2022) -
Rapid monitoring of health services use following a policy to switch patients from originator to biosimilar etanercept—a cohort study in British Columbia
por: Fisher, Anat, et al.
Publicado: (2022) -
Policy‐induced selection bias in pharmacoepidemiology: The example of coverage for Alzheimer's medications in British Columbia
por: Fisher, Anat, et al.
Publicado: (2019) -
Treatment pattern trends of medications for type 2 diabetes in British Columbia, Canada
por: Carney, Greg, et al.
Publicado: (2022) -
Antihypertensive medications and risk of colorectal cancer in British Columbia
por: Qi, Jia, et al.
Publicado: (2023)